Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Pfizer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.

Pfizer

SOLVE FSHD announces the appointment of Dr Eva Chin as its executive director

SOLVE FSHD announces the appointment of Dr Eva Chin as its executive director

Dr Chin’s has an extensive background in the academic and pharmaceutical industries, having previously held positions at Pfizer, the University of Maryland, MyoTherapeutics, Cytokinetics and NMD Pharma. ... At Pfizer, her career evolved from academic

Pfizer to acquire Biohaven in deal worth over $11bn

Pfizer to acquire Biohaven in deal worth over $11bn The deal will expand Pfizer’s Internal Medicine pipeline. Pfizer has announced it will acquire Biohaven Pharmaceutical, the makers of a US-approved dual-acting migraine therapy. ... Today’s announcement builds on our legacy of delivering

UK trial of fourth vaccine dose shows increased protection against COVID-19

UK trial of fourth vaccine dose shows increased protection against COVID-19 Participants in the study included 70-year-olds and some under 70, and all received a dose of Pfizer or a half dose of Moderna around six months after having their

Pfizer and Valneva announce positive phase 2 paediatric data for lyme disease vaccine

Pfizer and Valneva announce positive phase 2 paediatric data for lyme disease vaccine Pfizer and Valneva have announced positive phase 2 paediatric results for their Lyme disease vaccine candidate, VLA15. ... Kathrin Jansen, senior vice president and head of vaccine R&D at Pfizer, said: “The medical need for vaccination against Lyme

NHS to offer two new treatments for drug-resistant superbugs as part of a new subscription-style payment plan

NHS to offer two new treatments for drug-resistant superbugs as part of a new subscription-style payment plan NHS England, the National Institute for Health and Care Excellence (NICE) and the UK Department of Health have concluded an assessment of Pfizer’s Zavicefta (ceftazidime with avibactam) and Shionogi’s ... Both Pfizer and Shionogi submitted the drugs

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...